Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma control

70Citations
Citations of this article
71Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The hallmark of atopic asthma is transient airways hyperresponsiveness (AHR) preceded by aeroallergen-induced Th-cell activation. This is preceded by upregulation of CD86 on resident airway dendritic cells (DCs) that normally lack competence in T-cell triggering. Moreover, AHR duration is controlled via T-regulatory (Treg) cells, which can attenuate CD86 upregulation on DC. We show that airway mucosal Treg/DC interaction represents an accessible therapeutic target for asthma control. Notably, baseline airway Treg activity in sensitized rats can be boosted by microbe-derived stimulation of the gut, resulting in enhanced capacity to control CD86 expression on airway DC triggered by aeroallergen and accelerated resolution of AHR. © 2011 Society for Mucosal Immunology.

Cite

CITATION STYLE

APA

Strickland, D. H., Judd, S., Thomas, J. A., Larcombe, A. N., Sly, P. D., & Holt, P. G. (2011). Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma control. Mucosal Immunology, 4(1), 43–52. https://doi.org/10.1038/mi.2010.43

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free